Report from a consensus conference on antibody-mediated rejection in heart transplantation

Journal of Heart and Lung Transplantation

Volumn 30, Issue 3, 2011, Pages 252-269

  Kobashigawa, Jon ^a   Crespo Leiro, Maria G ^b   Ensminger, Stephan M ^c   Reichenspurner, Hermann ^d   Angelini, Annalisa ^e   Berry, Gerald ^f   Burke, Margaret ^g   Czer, Lawrence ^a   Hiemann, Nicola ^h   Kfoury, Abdallah G ⁱ   Mancini, Donna ^j   Mohacsi, Paul ^k   Patel, Jignesh ^a   Pereira, Naveen ^l   Platt, Jeffrey L ^m   Reed, Elaine F ⁿ   Reinsmoen, Nancy ^a   Rodriguez, E Rene ^o   Rose, Marlene L ^g   Russell, Stuart D ^p   Starling, Randy ^o   Suciu Foca, Nicole ^q   Tallaj, Jose ^r   Taylor, David O ^o   Van Bakel, Adrian ^s   West, Lori ^t   Zeevi, Adriana ^u   Zuckermann, Andreas ^v   more..

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b Hospital Universitario A Corua   (Spain)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e UNIVERSITY OF PADOVA   (Italy)

^f STANFORD UNIVERSITY   (United States)

^g HAREFIELD HOSPITAL   (United Kingdom)

^h DEUTSCHES HERZZENTRUM BERLIN   (Germany)

ⁱ INTERMOUNTAIN MEDICAL CENTER   (United States)

^j New York Presbyterian Hospital Columbia University Medical Center   (United States)

^k UNIVERSITY OF BERN   (Switzerland)

^l MAYO CLINIC   (United States)

^m UNIVERSITY OF MICHIGAN   (United States)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

^o LERNER RESEARCH INSTITUTE   (United States)

^p JOHNS HOPKINS HOSPITAL   (United States)

^q Cleveland Clinic ^*  (United States)

^r UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^s MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^t UNIVERSITY OF ALBERTA   (Canada)

^u UNIVERSITY OF PITTSBURGH   (United States)

^v MEDICAL UNIVERSITY OF VIENNA   (Austria)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; CYCLOSPORIN; ECULIZUMAB; EVEROLIMUS; IMMUNOGLOBULIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY CLASS I RELATED CHAIN A; MAJOR HISTOCOMPATIBILITY CLASS I RELATED CHAIN B; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; RITUXIMAB; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG; VIMENTIN;

ANTIBODY MEDIATED REJECTION; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CONSENSUS; DONOR; DRUG EFFICACY; ENDOTHELIUM CELL; GRAFT REJECTION; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IRRADIATION; PLASMAPHERESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUVA;

ANTIBODIES; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; TREATMENT OUTCOME;

EID: 79551666061     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2010.11.003     Document Type: Article

References (100)

1. H. Eisen, and H. Ross Optimizing the immunosuppressive regimen in heart transplantation J Heart Lung Transplant 23 2004 S207 S213
2. G.A. Cogert, S. Subherwal, and G. Wu Incidence of non-cellular (humoral) rejection unchanged in the 1990 decade despite a decrease in cellular rejection J Heart Lung Transplant 22 2003 S119 S142
3. R.B. Colvin, and R.N. Smith Antibody-mediated organ-allograft rejection Nat Rev Immunol 5 2005 807 817
4. P.J. Michaels, M.L. Espejo, and J.A. Kobashigawa Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease J Heart Lung Transplant 22 2003 58 69
5. A.G. Kfoury, J. Stehlik, and D.G. Renlund Impact of repetitive episodes of antibody-mediated or cellular rejection on cardiovascular mortality in cardiac transplant recipients: defining rejection patterns J Heart Lung Transplant 25 2006 1277 1282
6. A.R. Tambur, S.V. Pamboukian, and M.R. Constanzao The presence of HLA-directed antibodies after heart transplantation is associated with poor allograft outcome Transplantation 80 2005 1019 1025
7. D.O. Taylor, R.L. Yowell, and A.G. Kfoury Allograft coronary artery disease clinical correlations with circulating anti-HLA antibodies and the immunohistopathologic pattern of vascular rejection J Heart Lung Transplant 19 2000 518 521
8. A. Herskowitz, L.M. Soule, and K. Ueda Arteriolar vasculitis on endomyocardial biopsy: A histologic predictor of poor outcome in cyclosporine-treated heart transplant recipients J Heart Transplant 6 1987 127
9. E.H. Hammond, R.L. Yowell, and S. Nunoda Vascular (humoral) rejection in heart transplantation (pathologic observations and clinical implications) J Heart Transplant 8 1989 430 443
10. E.F. Reed, A.J. Demetris, and E. Hammond Acute antibody mediated rejection of cardiac transplants J Heart Lung Transplant 25 2006 153
11. S.H. Leech, S. Rubin, and H.J. Eisen Cardiac transplantation across a positive prospective lymphocyte cross-match in sensitized recipients Clin Transplant 17 suppl 9 2003 17 26
12. E.H. Hammond, C.T. Wittwer, and J. Greenwood Relationship of OKT3 sensitization and vascular rejection in cardiac transplant patients receiving OKT3 rejection prophylaxis Transplantation 50 1990 776
13. M. Toyoda, A. Petrosian, and S.C. Jordan Immunological characterization of anti-endothelial cell antibodies induced by cytomegalovirus infection Transplantation 68 1999 1311
14. J. Kobashigawa Contemporary concepts in non-cellular rejection Heart Fail Clin 3 2007 11 15
15. M.W. Baldwin 3rd, K.E. Kasper, and A.A. Zachary Beyond C4d: other complement related diagnostic approaches to antibody-mediated rejection Am J Transplant 4 2004 311 318
16. N.C. Morrell, K. Murata, and M.A. Swaim In vivo platelet endothelial interactions in response to major histocompatibility complex antibody Circ Res 102 2008 777 785
17. X. Zhang, and F.E. Reed Effect of antibodies on endothelium Am J Transplant 9 2009 2459 2465
18. J.E. Lepin, Q. Zhang, and X. Zhang Phosphorylated S6 ribosomal protein: a novel biomarker of antibody-mediated rejection in heart allografts Am J Transplant 6 2006 1560 1571
19. S. Banu, and F.P. Halloran Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection Curr Opin Organ Transplant 15 2010 42 48
20. S. Banu, S.G. Jhangri, and S. Bunnag Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining Am J Transplant 9 2009 2312 2323
21. S. Stewart, G.L. Winters, and M.C. Fishbein Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection J Heart Lung Transplant 24 2005 1710 1720
22. M. Burke, C. Andersen, and M. Ashworth C4d methodology and interpretation in biopsy diagnosis of cardiac antibody-mediated rejection: A European survey from the Transplant Working Group of the Association for European Cardiovascular Pathology (AECVP) J Heart Lung Transplant 29 2010 S37 S38
23. S.K. Takemoto, A. Zeevi, and S. Feng National conference to assess antibody-mediated rejection in solid organ transplantation Am J Transplant 4 2004 1033 1034
24. J.Z. Appel, M.G. Hartwig, and E. Cantu Role of flow cytometry to define unacceptable HLA antigens in lung transplant recipients with HLA-specific antibodies Transplantation 81 2006 1049
25. A.A. Zachary, J.T. Sholander, and J.A. Houp Using real data for a virtual crossmatch Hum Immunol 70 2009 574
26. N.L. Reinsmoen, C.H. Lai, and A. Vo Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy Transplantation 86 2008 820
27. P. Amico, G. Hnger, and D. Bielmann Incidence and prediction of early antibody-mediated rejection due to non-human leukocyte antigen-antibodies Transplantation 85 2008 1557 1563
28. M.E. Breimer, L. Rydberg, and A.M. Jackson Multicenter evaluation of a novel endothelial cell crossmatch test in kidney transplantation Transplantation 87 2009 549 556
29. H.A. Stephens MICA and MICB genes: can the enigma of their polymorphism be resolved? Trends Immunol 22 2001 378 385
30. B. Surez-Alvarez, A. Lpez-Vzquez, and M.Z. Gonzalez The relationship of anti-MICA antibodies and MICA expression with heart allograft rejection Am J Transplant 7 2007 1842 1848
31. J.D. Smith, V.M. Brunner, and S. Jigjidsuren Lack of effect of MICA antibodies on graft survival following heart transplantation Am J Transplant 9 2009 1912 1919
32. M.J. Dunn, M.L. Rose, and N. Latif Demonstration by western blotting of antiheart antibodies before and after cardiac transplantation Transplantation 51 1991 806 812
33. R.P. Laguens, M.I. Argel, and J.G. Chamb Anti-skeletal muscle glycolipid antibodies in human heart transplantation as markers of acute rejection Correlation with endomyocardial biopsy Transplantation 62 1996 211 216
34. R. Fredrich, M. Toyoda, and L.S. Czer The clinical significance of antibodies to human vascular endothelial cells after cardiac transplantation Transplantation 67 1999 385 389
35. S. Jurcevic, M.E. Ainsworth, and A. Pomerance Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation Transplantation 71 2001 886 892
36. T.A. Goers, S. Ramachandran, and A. Aloush De novo production of K-alpha1 tubulin-specific antibodies: role in chronic lung allograft rejection J Immunol 180 2008 4487 4494
37. J.D. Smith, I.M. Hamour, and M.M. Burke A reevaluation of the role of IgM Non-HLA antibodies in cardiac transplantation Transplantation 87 2009 864 871
38. G. Opelz Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies Lancet 365 2005 1570 1576
39. N. Fukami, S. Ramachandran, and D. Saini Antibodies to MHC class I induce autoimmunity: role in the pathogenesis of chronic rejection J Immunol 182 2009 309 318
40. B. Mahesh, H.S. Leong, and A. McCormack Autoantibodies to vimentin cause accelerated rejection of cardiac allografts Am J Pathology 170 2007 1415 1427
41. T.S. Win, S. Rehakova, and M.C. Negus Donor CD4 T cells contribute to cardiac allograft vasculopathy by providing help for autoantibody production Circ Heart Fail 2 2009 361 369
42. M.W. Chopek, R.L. Simmons, and J.L. Platt ABO-incompatible renal transplantation: initial immunopathologic evaluation Transplant Proc 19 1987 4553 4557
43. A.D. Bannett, R.F. McAlack, and M. Morris ABO incompatible renal transplantation: a qualitative analysis of native endothelial tissue ABO antigens after transplant Transplant Proc 21 1989 783 785
44. J.L. Platt, G.M. Vercellotti, and A.P. Dalmasso Transplantation of discordant xenografts: a review of progress Immunol Today 11 1990 450 456
45. S.S. Lin, B.C. Weidner, and G.W. Byrne The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants J Clin Invest 101 1998 1745 1756
46. W. Parker, Z.E. Holzknecht, and A. Song Fate of antigen in xenotransplantation: implications for acute vascular rejection and accommodation Am J Pathol 152 1998 829 839
47. W. Parker, S.S. Lin, and J.L. Platt Antigen expression in xenotransplantation: how low must it go? Transplantation 71 2001 313 319
48. J.L. Platt, and K.A. Nath Heme oxygenase: protective gene or Trojan horse Nat Med 4 1998 1364 1365
49. P.T. Jindra, X. Zhang, and A. Mulder Anti-HLA antibodies can induce endothelial cell survival or proliferation depending on their concentration Transplantation 82 2006 S33 S35
50. P.B. Yu, Z.E. Holzknecht, and D. Bruno Modulation of natural IgM binding and complement activation by natural IgG antibodies J Immunol 157 1996 5163 5168
51. Y. Yuzawa, J. Brett, and A. Fukatsu Interaction of antibody with forssman antigen in guinea pigs Am J Pathol 146 1995 1260 1272
52. A.P. Dalmasso, B.A. Benson, and J.S. Johnson Resistance against the membrane attack complex of complement induced in porcine endothelial cells with a Gal alpha(1-3)Gal binding lectin: up-regulation of CD59 expression J Immunol 164 2000 3764 3773
53. J.M. Williams, Z.E. Holzknecht, and T.B. Plummer Acute vascular rejection and accommodation: divergent outcomes of the humoral response to organ transplantation Transplantation 78 2004 1471 1478
54. T.W. Casarez, G. Perens, and R.J. Williams Humoral rejection in pediatric orthotopic heart transplantation J Heart Lung Transplant 26 2007 114 119
55. G.W. Wu, J.A. Kobashigawa, and M.C. Fishbein Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes J Heart Lung Transplant 28 2009 417 422
56. A.G. Kfoury, M.E. Hammond, and G.L. Snow Cardiovascular mortality among heart transplant recipients with asymptomatic antibody-mediated or stable mixed cellular and antibody-mediated rejection J Heart Lung Transplant 28 2009 781 784
57. W.E. Uber, S.E. Self, and A.B. Van Bakel Acute antibody-mediated rejection following heart transplantation Am J Transplant 7 2007 2064 2074
58. S.S. Kelishadi, A.M. Azimzadeh, and T. Zhang Preemptive CD20+ B cell depletion attenuates cardiac allograft vasculopathy in cyclosporine-treated monkeys J Clin Invest 120 2010 1275 1284
59. S.M. Pollock-BarZiv, N.D. Hollander, and B.Y. Ngan Pediatric heart transplantation in human leukocyte antigen-sensitized patients: evolving management and assessment of intermediate-term outcomes in a high-risk population Circulation 116 suppl I 2007 I-172 8
60. J. Stehlik, N. Islam, and D. Hurst Utility of virtual crossmatch in sensitized patients awaiting heart transplantation J Heart Lung Transplant 28 2009 1129 1134
61. E.S. Bishay, D.J. Cook, and R.C. Starling The clinical significance of flow cytometry crossmatching in transplantation Eur J Cardiothorac Surg 17 2000 362 369
62. M.G. Crespo-Leiro, A. Veiga-Barreiro, and N. Domenech Humoral heart rejection (severe allograft dysfunction with no signs of cellular rejection or ischemia): incidence, management, and the value of C4d for diagnosis Am J Transplant 5 2005 2560 2564
63. N. Singh, J. Pirsch, and M. Samaniego Antibody-mediated rejection: treatment alternatives and outcomes Transplant Rev (Orlando) 23 2009 34 46
64. R.M. Ratkovec, E.H. Hammond, and J.B. O'Connell Outcome of cardiac transplant recipients with a positive donor-specific crossmatchpreliminary results with plasmapheresis Transplantation 54 1992 651 655
65. O. Grauhan, C. Knosalla, and R. Ewert Plasmapheresis and cyclophosphamide in the treatment of humoral rejection after heart transplantation J Heart Lung Transplant 20 2001 316 321
66. B. Coiffier, E. Lepage, and J. Briere CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma N Engl J Med 346 2002 235 242
67. J.C. Edwards, L. Szczepanski, and J. Szechinski Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis N Engl J Med 350 2004 2572 2581 (Pubitemid 38758544)
68. N. Milpied, B. Vasseur, and N. Parquet Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients Ann Oncol 11 suppl 1 2000 113 116
69. P. Halloran Immunosuppressive drugs for kidney transplantation N Engl J Med 351 2004 2715 2729
70. H.E. Garrett Jr, D. Duvall-Seaman, and B. Helsley Treatment of vascular rejection with rituximab in cardiac transplantation J Heart Lung Transplant 24 2005 1337 1342
71. I.C. Balfour, A. Fiore, and R.J. Graff Use of rituximab to decrease panel-reactive antibodies J Heart Lung Transplant 24 2005 628 630
72. I. Kaczmarek, M.A. Deutsch, and S. Sadoni Successful management of antibody-mediated cardiac allograft rejection with combined immunoadsorption and anti-CD20 monoclonal antibody treatment: case report and literature review J Heart Lung Transplant 26 2007 511 515
73. J.D. Christie, L.B. Edwards, and P. Aurora The Registry of the International Society for Heart and Lung Transplantation: twenty-sixth official adult lung and heart-lung transplantation report2009 J Heart Lung Transplant 28 2009 1031 1049
74. J.A. Kobashigawa, L.W. Miller, and S.D. Russell Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report Am J Transplant 6 2006 1377 1386
75. E.R. Rodriguez, D.V. Skojec, and C.D. Tan Antibody-mediated rejection in human cardiac allografts: evaluation of immunoglobulins and complement activation products C4d and C3d as markers Am J Transplant 5 2005 2778 2785
76. D.G. Renlund, J.B. O'Connell, and E.M. Gilbert A prospective comparison of murine monoclonal CD-3 (OKT3) antibody-based and equine antithymocyte globulin-based rejection prophylaxis in cardiac transplantation Decreased rejection and less corticosteroid use with OKT3 Transplantation 47 1989 599 605
77. J.S. Ladowski, T. Dillon, and M.H. Schatzlein Prophylaxis of heart transplant rejection with either antithymocyte globulin-, Minnesota antilymphocyte globulin-, or an OKT3-based protocol J Cardiovasc Surg (Torino) 34 1993 135 140
78. P.S. Macdonald, J. Mundy, and A.M. Keogh A prospective randomized study of prophylactic OKT3 versus equine antithymocyte globulin after heart transplantationincreased morbidity with OKT3 Transplantation 55 1993 110 116
79. B. Schnetzler, P. Leger, and A. Vlp A prospective randomized controlled study on the efficacy and tolerance of two antilymphocytic globulins in the prevention of rejection in first-heart transplant recipients Transpl Int 15 2002 317 325
80. L.S. De Santo, A. Della Corte, and G. Romano Midterm results of a prospective randomized comparison of two different rabbit-antithymocyte globulin induction therapies after heart transplantation Transplant Proc 36 2004 631 637
81. M. Velez, and M.R. Johnson Management of allosensitized cardiac transplant candidates Transplant Rev (Orlando) 23 2009 235 247
82. J.J. Everly, R.C. Walsh, and R.R. Alloway Proteasome inhibition for antibody-mediated rejection Curr Opin Organ Transplant 14 2009 662 666
83. M.J. Everly, J.J. Everly, and B. Susskind Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection Transplantation 86 2008 1754 1761
84. H.L. Trivedi, P.I. Terasaki, and A. Feroz Abrogation of anti-HLA antibodies via proteasome inhibition Transplantation 87 2009 1555 1561
85. R. Sberro-Soussan, J. Zuber, and C. Suberbielle-Boissel Bortezomib as the sole post-renal transplantation desensitization agent does not decrease donor-specific anti-HLA antibodies Am J Transplant 10 2010 681 686
86. J. Patel, M. Kittleson, and E. Reed The effectiveness of a standardized desensitization protocol in reducing calculated panel reactive antibodies (cPRA) in sensitized heart transplant candidates: does it make sense to desensitize? J Heart Lung Transplant 29 2010 S103 S104
87. M.D. Stegall, T.S. Diwan, and J.M. Burns Prevention of acute humoral rejection with C5 inhibition Am J Transplant 2009 9 :Abstract 178
88. S.P. Salter, M.M. Salter, and J.K. Kirklin Total lymphoid irradiation in the treatment of early or recurrent heart transplant rejection Int J Radiat Oncol Biol Phys 33 1995 83 88
89. J.K. Kirklin, R.N. Brown, and S.T. Huang Rejection with hemodynamic compromise: objective evidence for efficacy of photopheresis J Heart Lung Transplant 25 2006 283 288
90. E.H. Hammond, J. Stehlik, and G. Snow Utility of histologic parameters in screening for antibody-mediated rejection of cardiac allograft: a study of 3,170 biopsies J Heart Lung Transplant 24 2005 2015
91. C.D. Tan, G.G. Sokos, and D.J. Pidwell Correlation of donor-specific antibodies, complement and its regulators with graft dysfunction in cardiac antibody-mediated rejection Am J Transplant 9 2009 2075
92. E.L. Moseley, C. Atkinson, and L.D. Sharples Deposition of C4d and C3d in cardiac transplants: a factor in the development of coronary artery vasculopathy J Heart Lung Transplant 29 2010 417 423
93. M. Fedrigo, A. Gambino, and F. Tona Can C4d immunostaining on endomyocardial biopsies be considered a prognostic biomarker in heart transplant recipients? Transplant 90 2010 791 798
94. C. Chantranuwat, J.H. Qiao, and J. Kobashigawa Immunoperoxidase staining for C4d on paraffin-embedded tissue in cardiac allograft endomyocardial biopsies: comparison to frozen tissue immunofluorescence Appl Immunohistochem Mol Morphol 12 2004 166 171
95. R.N. Smith, N. Brousaides, and L. Grazette C4d deposition in cardiac allografts correlates with alloantibody J Heart Lung Transplant 24 2005 1202 1210
96. S.E. Fedson, S.S. Daniel, and A.N. Husain Immunohistochemistry staining of C4d to diagnose antibody-mediated rejection in cardiac transplantation J Heart Lung Transplant 27 2008 372 379
97. D.V. Miller, A.C. Roden, and J.D. Gamez Detection of C4d deposition in cardiac allografts A comparative study of immunofluorescence and immunoperoxidase methods Arch Pathol Lab Med 134 2010 1679 1684
98. E.K. Ho, G. Vlad, and A.I. Colovai Alloantibodies in heart transplantation Hum Immunol 70 2009 825 829
99. N. Suciu-Foca, E. Reed, and C. Marboe The role of Anti-HLA antibodies in heart transplantation Transplantation 51 1991 716 724
100. N.L. Reinsmoen, K. Nelson, and A. Zeevi Anti-HLA antibody analysis and crossmatching in heart and lung transplantation Transpl Immunol 13 2004 63 71